Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial
PaperCitations, authors & open-access status
Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 492 citations, 2017 year and closed oa status.
492
Citations
2017
Year
closed
OA Status